Reducing aluminosilicate scale in the Bayer process

US9944534B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9944534-B2
Application numberUS-201615346106-A
CountryUS
Kind codeB2
Filing dateNov 8, 2016
Priority dateSep 25, 2009
Publication dateApr 17, 2018
Grant dateApr 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides a method of inhibiting the accumulation of DSP scale in the liquor circuit of Bayer process equipment. The method includes adding one or more particular silane based small molecules to the liquor fluid circuit. These scale inhibitors reduce DSP scale formation and thereby increase fluid throughput, increase the amount of time Bayer process equipment can be operational and reduce the need for expensive and dangerous acid washes of Bayer process equipment. As a result, the invention provides a significant reduction in the total cost of operating a Bayer process.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of reducing aluminosilicate containing scale in a Bayer process comprising: adding to a Bayer process stream upstream from or at a heat exchanger a composition comprising a non-polymeric molecule comprising at least three components, wherein a first component of the at least three components is tetraethylene pentaamine (“TEPA”); a second component of the at least three components is 3-glycidoxypropyltrimethyloxysilane; and a third component of the at least three components is t-butyl glycidyl ether. 2. The method of claim 1 , wherein the first component, the second component, and the third component are present in the non-polymeric molecule at a mole ratio ranging from about 1.0:1.0:0.5 to about 1.0:3.0:2.0. 3. The method of claim 1 , wherein the first component, the second component, and the third component are present in the non-polymeric molecule at a mole ratio ranging from about 1.0:1.0:0.5 to about 1.0:2.0:1.0. 4. The method of claim 1 , wherein the first component, the second component, and the third component are present in the non-polymeric molecule at a mole ratio of about 1.0:2.0:0.8. 5. The method of claim 1 , wherein the composition is a solid. 6. The method of claim 1 , wherein the non-polymeric molecule is isolated as an unhydrolized alkoxysilane protected with methyl or ethyl ether groups. 7. The method of claim 1 , wherein the composition is a gel, a liquid, a solid, or a powder. 8. The method of claim 1 , wherein the composition is added to the Bayer process stream in an amount of from about 20 ppm to about 80 ppm. 9. The method of claim 1 , wherein the composition is added to the Bayer process stream in an amount of from about 50 ppm to about 60 ppm. 10. The method of claim 1 , wherein the non-polymeric molecule comprises 2 mole equivalents of 3-glycidoxypropyltrimethyloxysilane per 1 mole equivalent of TEPA. 11. The method of claim 1 , wherein the composition comprising the non-polymeric molecule is treated with from about 0.2 mole to about 0.5 mole di-oxirane coupling agent per mole of amine present in the non-polymeric molecule, the di-oxirane coupling agent having the structure: where n=1, 2, 4, or 6. 12. The method of claim 11 , wherein the first component, the second component, the third component, and the di-oxirane coupling agent are present in the composition at a mole ratio ranging from about 1.0:2.0:0.8:0.25 to about 1.0:2.0:0.5:0.5. 13. The method of claim 11 , wherein the composition is added to the Bayer process stream in an amount of from about 20 ppm to about 80 ppm. 14. The method of claim 11 , wherein the composition is added to the Bayer process stream in an amount of from about 50 ppm to about 60 ppm. 15. The method of claim 11 , wherein the non-polymeric molecule comprises 2 mole equivalents of 3-glycidoxypropyltrimethyloxysilane per 1 mole equivalent of TEPA.

Assignees

Inventors

Classifications

  • containing nitrogen (C02F5/14 takes precedence) · CPC title

  • without C-silicon linkages · CPC title

  • from metallurgical processes, i.e. from the production, refining or treatment of metals, e.g. galvanic wastes · CPC title

  • Purification of aluminium oxide, aluminium hydroxide or aluminates (C01F7/028 takes precedence) · CPC title

  • Making-up the alkali hydroxide solution from recycled spent liquor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9944534B2 cover?
The invention provides a method of inhibiting the accumulation of DSP scale in the liquor circuit of Bayer process equipment. The method includes adding one or more particular silane based small molecules to the liquor fluid circuit. These scale inhibitors reduce DSP scale formation and thereby increase fluid throughput, increase the amount of time Bayer process equipment can be operational and…
Who is the assignee on this patent?
Nalco Co, Ecolab Usa Inc
What technology area does this patent fall under?
Primary CPC classification C01F7/0633. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).